Brivazens
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 2759  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  » Next article
  » Previous article 
  » Table of Contents
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
  »  Article in PDF (241 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  References

 Article Access Statistics
    Viewed3436    
    Printed213    
    Emailed0    
    PDF Downloaded148    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
CORRESPONDENCE
Year : 2009  |  Volume : 57  |  Issue : 6  |  Page : 837

Imaging for diagnosis of Marchiafava-Bignami disease


Wiwanitkit House, Bangkhae, Bangkok - 10160, Thailand

Date of Acceptance15-Dec-2009
Date of Web Publication30-Jan-2010

Correspondence Address:
Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok - 10160
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.59505

Rights and Permissions



How to cite this article:
Wiwanitkit V. Imaging for diagnosis of Marchiafava-Bignami disease. Neurol India 2009;57:837

How to cite this URL:
Wiwanitkit V. Imaging for diagnosis of Marchiafava-Bignami disease. Neurol India [serial online] 2009 [cited 2023 Nov 30];57:837. Available from: https://www.neurologyindia.com/text.asp?2009/57/6/837/59505


Sir,

I read the two recent publications on imaging for the diagnosis of Marchiafava-Bignami disease (MBD) with great interest. [1],[2] Both the reports showed success in the use of high technology neuro imaging in the diagnosis of MBD. However, whether the new imaging approach is an actually good diagnostic approach for MBD is still questionable. The sensitivity and specificity of the test has to be assessed. Indeed, due to the nature of imaging technology, not a pathological examination, the definitive diagnosis cannot be expected. Indeed, the difference in the details of imaging findings in both the reports can be seen and can be a good supportive evidence for this argument.[1],[2] Second, the MBD is an extremely rare disease, using of imaging technology as a screening cannot be cost effective at all. The use of good clinical practice, good history taking and physical examination, might provide similar outcome of case management since most cases of MBD are usually suspected at rather late stages.

 
 » References Top

1.Bano S, Mehra S, Yadav SN, Chaudhary V. Marchiafava-Bignami disease: Role of neuroimaging in the diagnosis and management of acute disease. Neurol India 2009;57:649-52.  Back to cited text no. 1  [PUBMED]  Medknow Journal  
2.Nalini A, Kovoor JM, Dawn R, Kallur KG. Marchiafava-Bignami disease: Two cases with magnetic resonance imaging and positron emission tomography scan findings. Neurol India 2009;57:644-8.  Back to cited text no. 2  [PUBMED]  Medknow Journal  



This article has been cited by
1 Diverse MRI findings and clinical outcomes of acute Marchiafava-Bignami disease
Wei Li, Chao Ran, Jun Ma
Acta Radiologica. 2021; 62(7): 904
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow